Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis (2014)
- Authors:
- USP affiliated authors: DUARTE, ALBERTO JOSE DA SILVA - FM ; BENARD, GIL - FM
- Unidade: FM
- DOI: 10.2340/00015555-1650
- Subjects: PSORÍASE; DERMATOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Acta dermato-venereologica
- ISSN: 0001-5555
- Volume/Número/Paginação/Ano: v. 94, n. 1, p. 26-31, 2014
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ORTIGOSA, Luciena Cegatto Martins et al. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, v. 94, n. 1, p. 26-31, 2014Tradução . . Disponível em: https://doi.org/10.2340/00015555-1650. Acesso em: 02 abr. 2026. -
APA
Ortigosa, L. C. M., Silva, L. C. R. da, Duarte, A. J. S., Takahashi, M. D. F., & Bebrad, G. (2014). Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, 94( 1), 26-31. doi:10.2340/00015555-1650 -
NLM
Ortigosa LCM, Silva LCR da, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2026 abr. 02 ] Available from: https://doi.org/10.2340/00015555-1650 -
Vancouver
Ortigosa LCM, Silva LCR da, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2026 abr. 02 ] Available from: https://doi.org/10.2340/00015555-1650 - Proliferative response to GP43, periodated GP43, and P. brasiliensis culture antigens in patients with or cured of paracoccidioidomycosis
- Expansion and suppressive capacity of regulatory T cells isolated from patients across the leprosy spectrum: a pilot study
- Different grades of IL-12p70 and IL-12 receptor Beta 2 expression characteriza the different clinical outcomes in paracoccidioidomycosis: role of IL-10
- Evaluation of P. brasiliensis phagocytosis by dentric cells of patients with Paracoccidioidomycosis and healthy individuals
- Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations
- Glycolipid Sensing and Innate Immunity in Paracoccidioidomycosis
- Evaluation of the in vitro anti-mycobacterium tuberculosis immunity in patients with moderate to severe psoriasis
- Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
- Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area
- Immunological mechanisms implicated in recovery or development of acute or chronic forms of paracoccidioidomycosis (PCM).
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
